Anti-melanoma differentiation-associated gene 5 and anti-Ro52 antibody-dual positive dermatomyositis accompanied by rapidly lung disease: Three case reports

Table 1 Comparison of cumulative survival rates of 200 patients with endometrial cancer based on clinical characteristics

Laboratory parameter	Case 1	Case 2	Case 3
Age	40	43	40
Gender	F	F	F
White cell counts (× 109/L) (3.5-9.5)	9.82	7.72	6.26
Haemoglobin (115-150)	139	97	100
Platelets (× 109/L) (126-350)	143	192	235
CRP (mg/L) (0-3)	3.46	6.07	1.84
ESR (mm/hour) (0-15)	7.6	47	58
AST (IU/L) (13-35)	430	206	414
ALT (IU/L) (7-40)	215	134	282
LDH (IU/L) (120-250)	482	380	470
CK (IU/L) (40-200)	1484	17	108
Albumin (g/L) (40-55)	27.5	32.9	27
Ferritin (ng/mL) (12-135)	1640.38	87.56	458.49
Procalcitonin (ng/mL) (0-0.5)
Basline level at admission	0.11	0.13	0.1
On the day of worsening	0.24	0.32	0.1
C3 (mg/dL) (0.75-1.35)	0.46	1.04	0.77
C4 (mg/dL) (0.09-0.36)	0.27	0.18	0.28
ANA screening	1/1000	1/1000	1/320
Fluorescent pattern of ANA	Cytoplasmic	Cytoplasmic	Cytoplasmic
Anti-MDA5	Positive	Positive	Positive
Anti-Ro52	Positive	Positive	Positive

CRP: C-reactive protein; ESR: Erythrocyte sedimentation rate; AST: Aspartate aminotransferase; ALT: Alanine transaminase; LDH: Lactate dehydrogenase; CK: Creatine kinase; ANA: Antinuclear antibody; Anti-MDA5: Anti-melanoma differentiation-associated gene 5.